Selective inhibitors of GSK-3β: a suitable therapy for Down syndrome?

被引:1
|
作者
Giacomini, A. [1 ]
Stagni, F. [1 ]
Emili, M. [1 ]
Guidi, S. [1 ]
Salvalai, M. E. [2 ]
Vidal-Sanchez, V. [3 ]
Grilli, M. [2 ]
Martinez-Cue Pesini, C. [3 ]
Bartesaghi, R. [1 ]
机构
[1] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
[2] Amedeo Avogadro Univ Eastern Piedmont, Dept Pharmaceut Sci, Novara, Italy
[3] Univ Cantabria, Dept Physiol & Pharmacol, Santander, Spain
关键词
NEUROGENESIS;
D O I
10.1016/j.euroneuro.2017.12.105
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.3.015
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [41] GSK-3 inhibitors and their potential in the treatment of Alzheimer's disease
    Kypta, RM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (10) : 1315 - 1331
  • [42] Role of Glycogen Synthase Kinase (GSK-3) in Type-2 Diabetes and GSK-3 Inhibitors as Potential Anti-Diabetics
    Gokhale, Kunal M.
    Tilak, Bhargav P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2013, 3 (03): : 196 - 199
  • [43] Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
    Medina, Miguel
    Castro, Ana
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 533 - 543
  • [44] The potential of GSK-3 inhibitors as novel anti-inflammatory drugs
    Noma, Toshihiro
    Takahashi, Fumi
    Arioka, Masaki
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S126 - S126
  • [45] MEDI 373-Potent and orally active GSK-3 inhibitors
    Gong, Leyi
    Tan, Claudia
    Hirschfeld, Don
    Hogg, Heather
    Peltz, Gary
    Grupe, Andrew
    Avnur, Zafrira
    Dunten, Pete
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [46] GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics
    Wada, Akihiko
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 1558 - 1570
  • [47] Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches
    Buonfiglio, Rosa
    Prati, Federica
    Bischetti, Martina
    Cavarischia, Claudia
    Furlotti, Guido
    Ombrato, Rosella
    MOLECULES, 2020, 25 (09):
  • [48] In vitro evaluation of the effects of potential GSK-3β inhibitors terbutaline and orciprenaline
    Uzunhisarcikli, Ebru
    TRAKYA UNIVERSITY JOURNAL OF NATURAL SCIENCES, 2024, 25 (01) : 73 - 80
  • [49] Protein modeling and virtual screening to discover novel GSK-3 inhibitors
    Sivaprakasam, Prasanna
    Daga, Pankaj R.
    Xie, Aihua
    Doerksen, Robert J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [50] GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors
    Curtis A Thorne
    Chonlarat Wichaidit
    Adam D Coster
    Bruce A Posner
    Lani F Wu
    Steven J Altschuler
    Nature Chemical Biology, 2015, 11 : 58 - 63